Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate 2Seventy Bio Inc before investing.

In this article, we go over a few key elements for understanding 2Seventy Bio Inc’s stock price such as:

• 2Seventy Bio Inc’s current stock price and volume
• Why 2Seventy Bio Inc’s stock price changed recently
• Upgrades and downgrades for TSVT from analysts
• TSVT’s stock price momentum as measured by its relative strength

About 2Seventy Bio Inc (TSVT)

Before we jump into 2Seventy Bio Inc’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

2seventy bio, Inc. is a cell and gene therapy company, which is focused on the research, development, and commercialization of transformative treatments for cancer. The Company's approach combines its knowledge in T cell engineering technology and lentiviral vector gene delivery approaches, experience in research, development, and manufacturing of cell therapies and a suite of technologies that can be selectively deployed to develop targeted cellular therapies for patients with cancer. Its advancing multiple clinical programs includes SC-DARIC33, for the treatment of pediatric patients with relapsed and refractory acute myeloid leukemia (AML), and bbT369, for the treatment of patients with B-cell non-Hodgkins lymphoma (B-NHL), as well as multiple preclinical programs, consisting of bbT4015, an engineered CAR T cell therapy targeting MUC16. Additionally, together with its partner Bristol Myers Squibb, the Company delivers Abecma to multiple myeloma patients in the United States.

Want to learn more about 2Seventy Bio Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about 2Seventy Bio Inc.

What Caused 2Seventy Bio Inc Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of March 28, 2024, there were 3 analysts who downgraded 2Seventy Bio Inc’s stock and 2 analysts who upgraded over the last month.

Additionally, you'll want to evaluate 2Seventy Bio Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on 2Seventy Bio Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

2Seventy Bio Inc’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about 2Seventy Bio Inc (TSVT) by visiting AAII Stock Evaluator.

Relative Price Strength of 2Seventy Bio Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of March 28, 2024, 2Seventy Bio Inc has a weighted four-quarter relative price strength of -9.59%, which translates to a Momentum Score of 35 and is considered to be Weak.

Want to learn more about how 2Seventy Bio Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

2Seventy Bio Inc Stock Price: Bottom Line

As of April 1, 2024, 2Seventy Bio Inc’s stock price is $5.79, which is up 8.22% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like 2Seventy Bio Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.